Peptide therapy TikTok claims: separating hype from human data

What did @moreroidsmorefoidz actually say?

The creator reviewed kisspeptin (called "kiss pepin" throughout), describing it as a peptide that raises LH and FSH, the gonadotropins that signal the testes to produce testosterone. They reported starting with a total testosterone of 792 ng/dL and reaching 1,600 ng/dL after two months on a stack of kisspeptin, clomiphene ("cholmaphine"), and HCG. They acknowledged upfront that kisspeptin "only works for like one in ten people" and gave it a 7/10 rating, crediting most of the testosterone gains to clomiphene and HCG rather than kisspeptin alone. They also reported feeling flushing shortly after dosing, which they treated as confirmation it was working. Their main recommendation: people coming off steroid cycles or TRT who want to restore fertility should consider kisspeptin.

Does the science back this up?

Kisspeptin biology is real and reasonably well-studied. The part about it driving gonadotropin release is solid science. The fertility and post-cycle applications are biologically plausible but far from proven in humans at scale.

Kisspeptin is a neuropeptide encoded by the KISS1 gene. It binds to GPR54 receptors in the hypothalamus and triggers pulsatile GnRH release, which then stimulates LH and FSH secretion from the pituitary. This is not fringe science. Dhillo et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that exogenous kisspeptin-54 significantly increased LH in healthy men. A later study by Jayasena et al. (2014, Clinical Endocrinology) found that kisspeptin administration increased LH pulse frequency in men with hypogonadotropic hypogonadism, which is directly relevant to what the creator was describing. The "1 in 10" efficacy claim is harder to pin down. That number does not appear in published literature and likely comes from anecdote.

What did they get wrong (or right)?

They got the basic mechanism right. The attribution problem is the real issue here.

Credit where it is due: kisspeptin does drive LH and FSH output. The creator even admitted "most of the testosterone gains are from clomiphene and HCG," which is honest and scientifically defensible. Clomiphene is a selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus, effectively tricking it into releasing more GnRH. HCG directly mimics LH at the testicular level. Doubling testosterone from 792 to 1,600 ng/dL while on all three compounds tells you almost nothing about what kisspeptin alone contributed. That is a confounded result, and presenting it as evidence for kisspeptin is misleading even if unintentionally. The flushing sensation as proof-of-concept is also not a reliable pharmacological signal. Flushing can be caused by numerous mechanisms and does not confirm gonadotropin activity. The recommendation to use this stack for post-cycle recovery is plausible in theory but lacks clinical trial support for that specific application.

What should you actually know?

Kisspeptin is a legitimate area of endocrine research. It is not a proven post-cycle therapy tool, and this stack review cannot tell you what kisspeptin did independently.

As of 2024, kisspeptin remains investigational. It is not FDA-approved for any indication. Most human studies have used pharmaceutical-grade kisspeptin-54 or kisspeptin-10 in controlled settings with careful dosing protocols. What circulates in peptide markets is largely unregulated, and purity and concentration can vary significantly. A review by George et al. (2012, Nature Reviews Endocrinology) outlines kisspeptin's therapeutic potential in reproductive disorders, but notes that translating this to reliable clinical protocols requires much more evidence. If you are coming off a steroid cycle and concerned about fertility, this is a conversation for a urologist or reproductive endocrinologist, not a TikTok stack. Clomiphene, for what it is worth, has actual clinical data for hypogonadism (Katz et al., 2012, BJU International). HCG also has established use in this context. Kisspeptin is the least-supported member of this particular trio.